Abtak Logo

pd-l1 News

Stay updated with the latest pd-l1 news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on pd-l1 topics.

fallback-img
soure image
18
BusinessNov 29, 2024 10:48 AM

Dr. Reddy's launches Toripalimab in India for treatment of Nasopharyngeal Carcinoma

First & only immuno-oncology drug approved by various regulatory authorities around the world Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. Toripalimab is a New Biological Entity (NBE). It is the only immuno-oncology drug approved by various regulatory authorities around the world such as United States Food and Drug Administration (USFDA), European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), and others for the treatment of adu ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.